PRDS

Pardes Biosciences, Inc. Common Stock
PRDS

Overview Fund Activity
Delisted

PRDS was delisted on the 30th of August, 2023.

Back to rankings

69 hedge funds and large institutions have $144M invested in Pardes Biosciences, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 16 increasing their positions, 20 reducing their positions, and 9 closing their positions.

Holders
69
Holders Change
+12
Holders Change %
+21.05%
% of All Funds
1.17%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.08%
New
21
Increased
16
Reduced
20
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
VS
1
VK Services
California
$18.9M
2
Goldman Sachs
2
Goldman Sachs
New York
$13.1M
3
BlackRock
3
BlackRock
New York
$4.93M
4
LCM
4
Lynx1 Capital Management
Puerto Rico
$6.69M
5
Geode Capital Management
5
Geode Capital Management
Massachusetts
$1.51M

Top Sellers

1
FLSM
1
Frazier Life Sciences Management
California
$2.6M
2
Janus Henderson Group
2
Janus Henderson Group
United Kingdom
$0
3
ACM
3
Altium Capital Management
New York
$0
4
T. Rowe Price Associates
4
T. Rowe Price Associates
Maryland
$3.95M
5
Wellington Management Group
5
Wellington Management Group
Massachusetts
$0
Name Market Value Shares Shares
Change 		Shares
Change %
FCMV
1
Foresite Capital Management V
California
$28.9M 9,400,515 – –
RCM
2
RA Capital Management
Massachusetts
$19M 6,175,038 – –
VS
3
VK Services
California
$18.9M 6,151,766 +6,151,766 New
FCOMV
4
Foresite Capital Opportunity Management V
California
$16M 5,227,307 – –
Goldman Sachs
5
Goldman Sachs
New York
$13.1M 4,275,914 +2,163,503 +102%
LCM
6
Lynx1 Capital Management
Puerto Rico
$6.69M 2,180,560 +537,726 +33%
BlackRock
7
BlackRock
New York
$4.93M 1,605,595 +1,261,808 +367%
T. Rowe Price Associates
8
T. Rowe Price Associates
Maryland
$3.95M 1,286,324 -530,235 -29%
PIM
9
Platinum Investment Management
Australia
$3.73M 1,215,967 -34,711 -3%
Vanguard Group
10
Vanguard Group
Pennsylvania
$3.38M 1,102,034 +116,060 +12%
ACA
11
Arena Capital Advisors
California
$2.61M 851,281 – –
FLSM
12
Frazier Life Sciences Management
California
$2.6M 845,636 -1,235,371 -59%
PHS
13
PFM Health Sciences
California
$2.46M 801,204 +70,847 +10%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$1.51M 490,892 +267,904 +120%
DCM
15
DAFNA Capital Management
California
$1.39M 451,105 +29,948 +7%
Adage Capital Partners
16
Adage Capital Partners
Massachusetts
$1.38M 450,000 – –
HMC
17
Harvard Management Company
Massachusetts
$1.23M 400,000 – –
C
18
Chescapmanager
Maryland
$1.11M 361,716 -224,310 -38%
State Street
19
State Street
Massachusetts
$1.03M 336,308 +253,888 +308%
SCM
20
Sio Capital Management
New York
$969K 315,564 – –
Point72 Asset Management
21
Point72 Asset Management
Connecticut
$818K 266,400 -165,734 -38%
Northern Trust
22
Northern Trust
Illinois
$715K 232,971 +182,875 +365%
Alyeska Investment Group
23
Alyeska Investment Group
Illinois
$691K 225,000 – –
IC
24
Ikarian Capital
Texas
$687K 223,934 -100,000 -31%
Charles Schwab
25
Charles Schwab
California
$629K 204,622 +57,818 +39%
1
2 3 4